WDR12

Across TCGA pan-cancer cohorts, WDR12 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated WDR12 data layer compared with 23 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher WDR12 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated WDR12 expression acts as an unfavorable survival marker.

HNSC, PRAD, and LIHC are the cancer types where WDR12 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	II,III,IV	0.202	0.674	.004	30	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
LIHC	DFS	Median	All	0.097	0.543	.033	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

WDR12–HNSC (OS)

Open the HNSC breakdown →